What is Ardent Health, Inc.'s earnings per share (EPS)?

Ardent Health, Inc. (ARDT) reported diluted earnings per share of $0.96 for fiscal year 2025. This represents a -39.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ardent Health, Inc. (ARDT) Financials

ARDT

Trailing 12 months to June 30, 2026

Revenue $6.4B +3.3% YoY

Net Income $78.2M -69.3% YoY

EPS (Diluted) $0.55 -70.1% YoY

Operating Cash Flow $514.3M +70.3% YoY

Market Cap $1.5B as of Oct 2, 2026

Price / Sales 0.2x on $6.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 18.6x on $78.2M net income, trailing 12 months to June 30, 2026

Price / Book 1.1x on $1.4B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 10, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ARDT SEC filings page.

Ardent Health, Inc. (ARDT) reported $6.4B in revenue over the twelve months to Jun 30, 2026, up 3.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARDT FY2025 2026-08-29

Rising revenue paired with weaker accounting margins but increasingly cash-generative working capital and a less leveraged balance sheet.

FY2025 operating cash flow reached $470.5M while net income fell to $135.8M; the divergence means cash conversion improved even as reported profitability weakened. Receivables declined to $686.1M while revenue climbed to $6.3B, making working-capital release a plausible contributor to that cash result rather than relying on profit alone.

Revenue expansion did not translate into earnings: net margin fell from 3.5% in FY2024 to 2.2% in FY2025. That compression occurred despite interest expense declining to $55.2M, indicating the earnings pressure was not simply a financing-cost effect.

Debt dependence moderated: debt-to-equity fell from 1.0x in FY2024 to 0.8x in FY2025 as equity expanded, reducing balance-sheet reliance on borrowing. Short-term liquidity also strengthened, with the current ratio at 2.0x, although that measures balance-sheet coverage rather than cash profitability.

Financial Health Signals

Financial health score not available

Ardent Health, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/8

Ardent Health, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

3.46x

For every $1 of reported earnings, Ardent Health, Inc. generates $3.46 in operating cash flow ($470.5M OCF vs $135.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.6B

YoY-1.4%

QoQ+1.3%

Ardent Health, Inc. generated $1.6B in revenue in Q2 2026. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is up 1.3%.

Net Income

$16.9M

YoY-76.8%

QoQ-57.6%

Ardent Health, Inc. reported $16.9M in net income in Q2 2026. This represents a decrease of 76.8% from the same quarter a year earlier. Against the prior quarter it is down 57.6%.

EPS (Diluted)

$0.12

YoY-76.9%

QoQ-57.1%

Ardent Health, Inc. earned $0.12 per diluted share (EPS) in Q2 2026. This represents a decrease of 76.9% from the same quarter a year earlier. Against the prior quarter it is down 57.1%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$724.5M

YoY+34.0%

QoQ+18.8%

Ardent Health, Inc. held $724.5M in cash against $1.1B in long-term debt as of Q2 2026.

Shares Outstanding

141M

YoY-1.4%

QoQ-1.6%

Ardent Health, Inc. had 141M shares outstanding in Q2 2026. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is down 1.6%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

1.0%

YoY-3.4pp

QoQ-1.4pp

Ardent Health, Inc.'s net profit margin was 1.0% in Q2 2026, showing the share of revenue converted to profit. This is down 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Return on Equity

1.3%

YoY-4.6pp

QoQ-1.7pp

Ardent Health, Inc.'s ROE was 1.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 4.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.7 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

ARDT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ARDT quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K
Revenue	$6.4B	$6.3B+6.0%	$6.0B+10.3%	$5.4B+5.5%	$5.1B
SG&A Expenses	$183.1M	$140.8M+6.3%	$132.4M+15.5%	$114.6M+52.2%	$75.3M
Interest Expense	$51.1M	$55.2M-15.8%	$65.6M-11.7%	$74.3M	N/A
Income Tax	$39.3M	$56.2M-11.3%	$63.4M+179.9%	$22.6M-50.9%	$46.1M
Net Income	$78.2M	$135.8M-35.4%	$210.3M+290.2%	$53.9M-71.5%	$188.9M
EPS (Basic)	N/A	$0.96-39.6%	$1.59+269.8%	$0.43-71.3%	$1.50
EPS (Diluted)	$0.55	$0.96-39.2%	$1.58+267.4%	$0.43-71.3%	$1.50
Diluted Shares (Avg)	N/A	141M+6.6%	133M+5.3%	126M0.0%	126M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.6B-1.4%	$1.6B+7.0%	$1.6B-0.1%	$1.6B+8.8%	$1.6B+11.9%	$1.5B+4.0%	$1.6B	$1.4B+5.2%
SG&A Expenses	$61.2M+87.7%	$48.6M+39.3%	$36.8M+0.3%	$36.5M+8.3%	$32.6M+12.0%	$34.9M+6.1%	$36.7M	$33.7M+16.2%
Interest Expense	$12.6M-14.7%	$12.2M-13.9%	$12.4M-8.5%	$13.9M-4.9%	$14.7M-18.9%	$14.2M-26.4%	$13.5M	$14.6M-23.2%
Income Tax	$8.5M-67.6%	$16.1M+5.7%	$18.1M-31.3%	-$3.4M-130.8%	$26.3M+72.7%	$15.2M+42.2%	$26.4M	$11.1M+52.3%
Net Income	$16.9M-76.8%	$39.9M-3.7%	$45.0M-60.6%	-$23.5M-189.2%	$73.0M+70.6%	$41.4M+53.0%	$114.2M	$26.3M+26.3%
EPS (Basic)	$0.12-76.9%	$0.28-6.7%	$0.31-63.5%	-$0.17-189.5%	$0.52+52.9%	$0.30+42.9%	$0.85+2933.3%	$0.19+11.8%
EPS (Diluted)	$0.12-76.9%	$0.28-3.4%	$0.32-61.9%	-$0.17-189.5%	$0.52+52.9%	$0.29+38.1%	$0.84+2900.0%	$0.19+11.8%
Diluted Shares (Avg)	143M+1.1%	142M+0.8%	N/A	141M+2.7%	142M+12.2%	141M+11.6%	N/A	138M+9.1%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

ARDT Balance Sheet

ARDT quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K
Total Assets	$5.3B+6.7%	$5.0B+4.7%	$4.7B	N/A
Current Assets	$2.1B+12.3%	$1.8B+13.3%	$1.6B	N/A
Cash & Equivalents	$709.6M+27.4%	$556.8M+27.2%	$437.6M-4.1%	$456.1M
Short-Term Investments	$0	$0	$0	$0
Inventory	$118.6M+3.0%	$115.1M+9.1%	$105.5M	N/A
Accounts Receivable	$686.1M-7.7%	$743.0M-4.2%	$775.5M	N/A
Long-Term Investments	$0	$0	$0	$0
Goodwill	$879.5M+3.2%	$852.1M+0.9%	$844.7M0.0%	$844.7M
Total Liabilities	$3.6B+5.0%	$3.4B-5.9%	$3.6B	N/A
Current Liabilities	$1.0B+10.7%	$945.4M-4.9%	$994.1M	N/A
Non-Current Liabilities	$2.6B+2.8%	$2.5B-6.3%	$2.7B	N/A
Long-Term Debt	$1.1B-0.9%	$1.1B-7.1%	$1.2B	N/A
Total Equity	$1.3B+13.8%	$1.1B+68.6%	$670.9M-35.5%	$1.0B
Retained Earnings	$501.6M+37.1%	$365.8M+135.3%	$155.5M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$5.3B+5.0%	$5.3B+7.0%	$5.3B+6.7%	$5.2B+7.4%	$5.0B+9.1%	$4.9B	$5.0B+4.7%	$4.8B
Current Assets	$2.1B+9.5%	$2.0B+14.7%	$2.1B+12.3%	$2.0B+15.8%	$1.9B+25.0%	$1.8B	$1.8B+13.3%	$1.7B
Cash & Equivalents	$724.5M+34.0%	$609.7M+23.2%	$709.6M+27.4%	$609.4M+8.2%	$540.6M+61.6%	$495.0M+32.8%	$556.8M+27.2%	$563.1M+26.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$116.0M-2.0%	$119.8M-0.4%	$118.6M+3.0%	$121.6M+12.3%	$118.4M+12.8%	$120.4M	$115.1M+9.1%	$108.2M
Accounts Receivable	$696.0M-8.3%	$686.0M-11.7%	$686.1M-7.7%	$729.4M+3.4%	$758.6M+5.2%	$776.5M	$743.0M-4.2%	$705.7M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$879.3M+0.2%	$879.3M+0.3%	$879.5M+3.2%	$877.5M+3.0%	$877.7M+3.0%	$876.6M	$852.1M+0.9%	$852.0M
Total Liabilities	$3.5B+4.7%	$3.5B+5.2%	$3.6B+5.0%	$3.5B+3.2%	$3.4B-1.9%	$3.3B	$3.4B-5.9%	$3.4B
Current Liabilities	$976.3M+10.8%	$951.5M+14.6%	$1.0B+10.7%	$943.2M+6.3%	$880.9M-3.0%	$830.1M	$945.4M-4.9%	$887.3M
Non-Current Liabilities	$2.6B+2.5%	$2.6B+2.1%	$2.6B+2.8%	$2.6B+2.1%	$2.5B-1.5%	$2.5B	$2.5B-6.3%	$2.5B
Long-Term Debt	$1.1B-1.6%	$1.1B-1.6%	$1.1B-0.9%	$1.1B+0.3%	$1.1B+0.8%	$1.1B	$1.1B-7.1%	$1.1B
Total Equity	$1.4B+7.6%	$1.3B+13.8%	$1.3B+13.8%	$1.2B+23.1%	$1.3B+69.6%	$1.2B+5.9%	$1.1B+68.6%	$1.0B-7.2%
Retained Earnings	$558.4M+16.3%	$541.5M+33.0%	$501.6M+37.1%	$456.7M+81.5%	$480.1M+113.1%	$407.2M	$365.8M+135.3%	$251.6M

ARDT Cash Flow Statement

ARDT quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K
Operating Cash Flow	$514.3M	$470.5M+49.4%	$315.0M+42.1%	$221.7M+678.0%	-$38.4M
Depreciation & Amortization	N/A	$155.7M+6.4%	$146.3M+3.9%	$140.8M+1.9%	$138.2M
Investing Cash Flow	-$211.9M	-$214.2M+2.8%	-$220.5M-59.8%	-$138.0M-396.2%	$46.6M
Financing Cash Flow	-$118.5M	-$103.5M-519.9%	$24.6M+124.1%	-$102.3M+62.2%	-$270.3M
Dividends Paid	N/A	N/A	$0	$0-100.0%	$174.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$196.7M+67.4%	-$60.2M-143.0%	$223.4M+86.9%	$154.4M+72.1%	$117.5M-2.4%	-$24.8M-68.7%	$119.6M+77.1%	$89.7M+1.2%
Depreciation & Amortization	$41.3M+5.2%	$43.0M+18.7%	$41.0M+8.4%	$39.2M+6.5%	$39.3M+8.3%	$36.2M+2.4%	$37.9M+5.2%	$36.8M+3.6%
Investing Cash Flow	-$39.2M+15.3%	-$27.9M-20.7%	-$86.2M+18.2%	-$58.6M-31.7%	-$46.2M-19.0%	-$23.1M+26.9%	-$105.4M-85.9%	-$44.5M-79.7%
Financing Cash Flow	-$42.8M-66.7%	-$11.8M+14.8%	-$37.0M-80.9%	-$26.9M-114.7%	-$25.7M+78.6%	-$13.8M+25.2%	-$20.5M-14.5%	$183.4M+867.1%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

ARDT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ARDT quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K
Net Margin	2.1%-1.4pp	3.5%+2.5pp	1.0%-2.7pp	3.7%
Return on Equity	10.5%-8.0pp	18.6%+10.6pp	8.0%-10.1pp	18.2%
Return on Assets	2.6%-1.7pp	4.2%+3.1pp	1.1%	N/A
Current Ratio	1.970.0x	1.94+0.3x	1.63	N/A
Debt-to-Equity	0.84-0.1x	0.96-0.8x	1.74	N/A
Asset Turnover	1.200.0x	1.20+0.1x	1.14	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	1.0%-3.4pp	2.5%-0.3pp	2.8%-4.3pp	-1.5%-3.3pp	4.4%+1.5pp	2.8%+0.9pp	7.1%	1.8%+0.3pp
Return on Equity	1.3%-4.6pp	3.0%-0.5pp	3.5%-6.6pp	-1.9%-4.5pp	5.8%0.0pp	3.5%+1.1pp	10.1%	2.6%+0.7pp
Return on Assets	0.3%-1.1pp	0.8%-0.1pp	0.9%-1.4pp	-0.5%-1.0pp	1.5%+0.5pp	0.8%	2.3%	0.5%
Current Ratio	2.100.0x	2.120.0x	1.970.0x	2.08+0.2x	2.13+0.5x	2.12	1.94+0.3x	1.91
Debt-to-Equity	0.79-0.1x	0.80-0.1x	0.84-0.1x	0.88-0.2x	0.87-0.6x	0.93	0.96-0.8x	1.08
Asset Turnover	0.310.0x	0.300.0x	0.300.0x	0.310.0x	0.330.0x	0.30	0.32	0.30

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Ardent Health, Inc. ARDT	FY2025	$6.3B	$135.8M	2.1%	$1.5B	—
P3 Health Partners Inc. PIII	FY2025	$1.5B	-$147.9M	-10.1%	$24.5M	24/100
Aveanna Healthcare Holdings Inc. AVAH	FY2026	$2.4B	$225K	0.0%	$2.7B	36/100
Guardian Pharmacy Services, Inc. GRDN	FY2025	$1.4B	$49.2M	3.4%	$2.6B	53/100
Brookdale Senior Living, Inc. BKD	FY2025	$3.2B	-$262.7M	-8.2%	$2.6B	25/100
National Healthcare Corp. NHC	FY2025	$1.5B	$120.0M	7.9%	$3.5B	67/100

Where Ardent Health, Inc. Ranks

Frequently Asked Questions

What is Ardent Health, Inc.'s annual revenue?

Ardent Health, Inc. (ARDT) reported $6.3B in total revenue for fiscal year 2025. This represents a 6.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ardent Health, Inc.'s revenue growing?

Ardent Health, Inc. (ARDT) revenue grew by 6.0% year-over-year, from $6.0B to $6.3B in fiscal year 2025.

Is Ardent Health, Inc. profitable?

Yes, Ardent Health, Inc. (ARDT) reported a net income of $135.8M in fiscal year 2025, with a net profit margin of 2.1%.

How much debt does Ardent Health, Inc. have?

As of fiscal year 2025, Ardent Health, Inc. (ARDT) had $709.6M in cash and equivalents against $1.1B in long-term debt.

What is Ardent Health, Inc.'s net profit margin?

Ardent Health, Inc. (ARDT) had a net profit margin of 2.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ardent Health, Inc.'s return on equity (ROE)?

Ardent Health, Inc. (ARDT) has a return on equity of 10.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ardent Health, Inc.'s operating cash flow?

Ardent Health, Inc. (ARDT) generated $470.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ardent Health, Inc.'s total assets?

Ardent Health, Inc. (ARDT) had $5.3B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Ardent Health, Inc. have outstanding?

Ardent Health, Inc. (ARDT) had 143M shares outstanding as of fiscal year 2025.

What is Ardent Health, Inc.'s current ratio?

Ardent Health, Inc. (ARDT) had a current ratio of 1.97 as of fiscal year 2025, which is generally considered healthy.

What is Ardent Health, Inc.'s debt-to-equity ratio?

Ardent Health, Inc. (ARDT) had a debt-to-equity ratio of 0.84 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ardent Health, Inc.'s return on assets (ROA)?

Ardent Health, Inc. (ARDT) had a return on assets of 2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ardent Health, Inc.'s P/E ratio?

Ardent Health, Inc. (ARDT) trades at 18.6x earnings, its market capitalization divided by net income of $78.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.5B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ardent Health, Inc.'s price-to-sales ratio?

Ardent Health, Inc. (ARDT) trades at 0.2x sales, its market capitalization divided by revenue of $6.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.5B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ardent Health, Inc.'s Piotroski F-Score?

Ardent Health, Inc. (ARDT) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ardent Health, Inc.'s earnings high quality?

Ardent Health, Inc. (ARDT) has an earnings quality ratio of 3.46x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.